These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Comparative bioavailability of two forms of spironolactone. Rationalization applied to dosage (author's transl)]. d'Athis P; Richard MO; de Lauture D; Rey E; Bouvier d'Yvoire M; Clement E; Olive G Therapie; 1981; 36(4):443-9. PubMed ID: 7292427 [No Abstract] [Full Text] [Related]
9. Spironolactone: disposition, metabolism, pharmacodynamics, and bioavailability. Karim A Drug Metab Rev; 1978; 8(1):151-88. PubMed ID: 363379 [No Abstract] [Full Text] [Related]
10. Interference in the measurement of plasma 11-hydroxycorticosteroids caused by spironolactone administration. Wood LC; Richards R; Ingbar SH N Engl J Med; 1970 Mar; 282(12):650-2. PubMed ID: 5417730 [No Abstract] [Full Text] [Related]
11. Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia. Terai I; Yamano K; Ichihara N; Arai J; Kobayashi K Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F179-83. PubMed ID: 10525019 [TBL] [Abstract][Full Text] [Related]
12. [Eplerenone for treatment of heart failure]. Yoshimura M Nihon Rinsho; 2007 May; 65 Suppl 5():153-8. PubMed ID: 17569313 [No Abstract] [Full Text] [Related]
13. [Comparative study of relative biovailability of several spironolactone formulations in a steady-state test (author's transl)]. Rosenthal J; Jaeger H; Specker M Arzneimittelforschung; 1979; 29(9):1428-32. PubMed ID: 583254 [TBL] [Abstract][Full Text] [Related]
14. A comparison of the dissolution and bioavailability characteristics of three spironolactone tablet formulations, including preliminary data on two spironolactone metabolites. Tidd MJ; Collins WT; Chamberlain J J Int Med Res; 1976; 4(2):86-95. PubMed ID: 1037443 [TBL] [Abstract][Full Text] [Related]
16. Validation of plasma and urinary canrenone for determination of bioavailability of spironolactone--comparison of tablets with solution/suspension. Tidd MJ; Ramsay LE; Shelton JR; Palmer RF Int J Clin Pharmacol Biopharm; 1977 May; 15(5):205-10. PubMed ID: 873663 [TBL] [Abstract][Full Text] [Related]
17. Spironolactone metabolism in normal subjects and in patients with liver cirrhosis. Váradi A; Fehér T; Bodrogi L; Koref O Arzneimittelforschung; 1977; 27(8):1618-20. PubMed ID: 578759 [TBL] [Abstract][Full Text] [Related]
18. Cortisol and cortisone analysis in serum and plasma by atmospheric pressure photoionization tandem mass spectrometry. Kushnir MM; Neilson R; Roberts WL; Rockwood AL Clin Biochem; 2004 May; 37(5):357-62. PubMed ID: 15087250 [TBL] [Abstract][Full Text] [Related]
19. [Normoaldosterone spironolactone sensitive hypertension--a case report]. Krysiak R; Okopień B; Herman ZS Pol Arch Med Wewn; 2005 Oct; 114(4):978-81. PubMed ID: 16789524 [TBL] [Abstract][Full Text] [Related]
20. Is canrenone the major metabolite of spironolactone? Merkus FW Clin Pharm; 1983; 2(3):209-10. PubMed ID: 6883952 [No Abstract] [Full Text] [Related] [Next] [New Search]